Total planned funding: $145,869,039
Allocations
Countries/Regions
India | $145,869,039 |
Organizational Types
Unknown | $78,073,236 |
NGO | $30,424,606 |
Own Agency | $22,044,389 |
University | $3,600,000 |
Multi-lateral Agency | $3,116,808 |
Implementing Agency | $3,100,000 |
FBO | $2,500,000 |
Private Contractor | $2,409,000 |
Host Country Government Agency | $601,000 |
Other USG Agency | $0 |
Program Areas
Governance and Systems | $63,069,393 |
Prevention | $33,492,084 |
Management and Operations | $17,150,564 |
Care | $14,800,354 |
Treatment | $6,833,050 |
Testing | $6,095,802 |
Budget Codes
OHSS: Health Systems Strengthening | $34,667,058 |
HVSI: Strategic Information | $20,663,621 |
HVMS: Management and Operations | $17,150,564 |
HVOP: Sexual Prevention: Other Sexual Prevention | $15,809,011 |
HBHC: Care: Adult Care and Support | $8,225,462 |
HLAB: Laboratory Infrastructure | $7,738,714 |
HTXS: Treatment: Adult Treatment | $6,115,285 |
HVCT: Testing: HIV Testing and Counseling | $6,095,802 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $5,833,114 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $5,538,766 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $4,181,945 |
HVTB: Care: TB/HIV | $3,898,284 |
HKID: Care: Orphans and Vulnerable Children | $2,201,846 |
HMBL: Biomedical Prevention: Blood Safety | $2,129,248 |
PDTX: Treatment: Pediatric Treatment | $694,288 |
PDCS: Care: Pediatric Care and Support | $474,762 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$78,073,236
Countries/Regions
USG Aggregated Agencies:
$16,928,352
Countries/Regions
FHI 360:
$13,783,871
Countries/Regions
Voluntary Health Services:
$4,050,000
Countries/Regions